2.49 USD
-0.08 (-3.11%)
2.53 USD
+0.04 (+1.61%)
Overall OSUR gets a fundamental rating of 2 out of 10. We evaluated OSUR against 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of OSUR is average, but there are quite some concerns on its profitability. OSUR is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
OSUR had negative earnings in the past year.
OSUR had a negative operating cash flow in the past year.
In the past 5 years OSUR reported 4 times negative net income.
In multiple years OSUR reported negative operating cash flow during the last 5 years.
1.2 Ratios
OSUR's Return On Assets of -14.24% is in line compared to the rest of the industry. OSUR outperforms 57.75% of its industry peers.
OSUR has a Return On Equity of -16.64%. This is in the better half of the industry: OSUR outperforms 63.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROIC | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of OSUR (40.41%) is worse than 67.91% of its industry peers.
In the last couple of years the Gross Margin of OSUR has declined.
OSUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
2. Health
2.1 Basic Checks
OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSUR has been increased compared to 1 year ago.
OSUR has more shares outstanding than it did 5 years ago.
OSUR has a better debt/assets ratio than last year.
2.2 Solvency
OSUR has an Altman-Z score of 1.78. This is a bad value and indicates that OSUR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.78, OSUR is in line with its industry, outperforming 57.75% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
The Debt to Equity ratio of OSUR (0.00) is better than 74.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.78 |
ROIC/WACCN/A
WACC8.82%
2.3 Liquidity
OSUR has a Current Ratio of 7.03. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 7.03, OSUR belongs to the best of the industry, outperforming 86.10% of the companies in the same industry.
OSUR has a Quick Ratio of 6.20. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR's Quick ratio of 6.20 is amongst the best of the industry. OSUR outperforms 87.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 |
3. Growth
3.1 Past
OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -633.33%.
Looking at the last year, OSUR shows a very negative growth in Revenue. The Revenue has decreased by -43.95% in the last year.
The Revenue has been growing slightly by 3.75% on average over the past years.
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
3.2 Future
The Earnings Per Share is expected to grow by 25.37% on average over the next years. This is a very strong growth
OSUR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.62% yearly.
EPS Next Y-239.35%
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue Next Year-38.37%
Revenue Next 2Y-20.05%
Revenue Next 3Y-11.49%
Revenue Next 5Y-4.62%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OSUR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OSUR's earnings are expected to decrease with -41.36% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%
5. Dividend
5.1 Amount
No dividends for OSUR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.49
-0.08 (-3.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners90.77%
Inst Owner Change-1.49%
Ins Owners5.52%
Ins Owner Change-0.08%
Market Cap178.61M
Revenue(TTM)125.70M
Net Income(TTM)-60.24M
Analysts80
Price Target4.59 (84.34%)
Short Float %5.62%
Short Ratio6.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.19%
Min EPS beat(2)-24.34%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-41.25%
Min EPS beat(4)-142.2%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-77.07%
EPS beat(12)8
Avg EPS beat(12)182.53%
EPS beat(16)9
Avg EPS beat(16)134.8%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.84%
Max Revenue beat(2)0.89%
Revenue beat(4)2
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-8.84%
Max Revenue beat(4)0.89%
Revenue beat(8)6
Avg Revenue beat(8)-0.34%
Revenue beat(12)10
Avg Revenue beat(12)7.45%
Revenue beat(16)14
Avg Revenue beat(16)8.57%
PT rev (1m)-25%
PT rev (3m)-25%
EPS NQ rev (1m)-10.81%
EPS NQ rev (3m)-20.59%
EPS NY rev (1m)0.57%
EPS NY rev (3m)-16.11%
Revenue NQ rev (1m)-15.21%
Revenue NQ rev (3m)-15.93%
Revenue NY rev (1m)-5.45%
Revenue NY rev (3m)-5.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.42 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.49 | ||
| P/tB | 0.59 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.56
OCFYN/A
SpS1.75
BVpS5.05
TBVpS4.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% | ||
| FCFM | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score2
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 36.29% | ||
| Cap/Sales | 2.97% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 | ||
| Altman-Z | 1.78 |
F-Score2
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y-239.35%
EPS Next 2Y-72.67%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
Revenue Next Year-38.37%
Revenue Next 2Y-20.05%
Revenue Next 3Y-11.49%
Revenue Next 5Y-4.62%
EBIT growth 1Y-539.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-91.42%
EBIT Next 3Y-4.37%
EBIT Next 5Y25.91%
FCF growth 1Y-157.36%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-148.56%
OCF growth 3YN/A
OCF growth 5Y22.81%
ORASURE TECHNOLOGIES INC / OSUR FAQ
What is the ChartMill fundamental rating of ORASURE TECHNOLOGIES INC (OSUR) stock?
ChartMill assigns a fundamental rating of 2 / 10 to OSUR.
Can you provide the valuation status for ORASURE TECHNOLOGIES INC?
ChartMill assigns a valuation rating of 0 / 10 to ORASURE TECHNOLOGIES INC (OSUR). This can be considered as Overvalued.
Can you provide the profitability details for ORASURE TECHNOLOGIES INC?
ORASURE TECHNOLOGIES INC (OSUR) has a profitability rating of 1 / 10.
How financially healthy is ORASURE TECHNOLOGIES INC?
The financial health rating of ORASURE TECHNOLOGIES INC (OSUR) is 5 / 10.